Vania Horta. Medical Affairs

Medical Affairs Lead · ABPI Final Signatory · London

Medical affairs built on scientific rigour — and materials signed off with confidence.

I help pharmaceutical teams in the UK and Europe turn complex clinical evidence into sound medical strategy, compliant materials and credible scientific relationships. Fifteen years across hospital pharmacy and industry, from NHS wards in Cambridge to medical leadership at CSL Vifor, Daiichi Sankyo, MSD and Pfizer.

15+years in pharmacy and pharmaceutical medicine
ABPI final signatory appointments — MSD, Daiichi Sankyo, CSL Vifor
6therapy areas, from rare diseases to oncology
5languages — Portuguese, English, Spanish, French, Greek
01

About

Medical affairs is where science, strategy and governance meet. It only works when all three are taken seriously.

I trained as a pharmacist in Lisbon and moved through community and hospital practice — including two and a half years as a rotational clinical pharmacist at Cambridge University Hospitals, covering clinical trials, oncology, neurology and aseptic services — before crossing into industry.

Since then I have held medical information, pharmacovigilance, medical review and medical affairs roles at Wockhardt, Pfizer, MSD, Daiichi Sankyo and CSL Vifor, where I currently lead medical affairs and act as final signatory. In 2023 I stepped up as interim Head of Field Medical Affairs for Rare Diseases, managing and coaching the field medical team.

That path — bench to bedside to boardroom — is the point. I review materials as someone who has dispensed the medicines, counselled the patients and defended the data. Colleagues come to me when they need a decision that is scientifically defensible, compliant with the ABPI Code, and commercially aware.

Experience gained at

  • CSL Vifor
  • Daiichi Sankyo
  • MSD
  • Pfizer
  • Wockhardt
  • Cambridge University Hospitals NHS
02

What I do

i.

Medical strategy & planning

Design and execution of country medical plans that hold up against brand objectives, launch milestones and the evidence itself.

ii.

Final signatory review

Certification of promotional and non-promotional materials under the ABPI Code of Practice — from concept to execution, without becoming a bottleneck.

iii.

Medical governance & compliance

Copy approval frameworks, responsible-person duties and the judgement calls that keep good projects out of trouble.

iv.

Scientific communications

Translating complex clinical data into clear, evidence-based materials for healthcare professionals and internal stakeholders.

v.

Field medical leadership

Coaching and performance management for MSL teams, and turning field insights into intelligence that local and global teams can act on.

vi.

Cross-functional & launch support

Medical input to marketing, regulatory, market access and commercial teams — advisory boards, launch planning and co-promotion agreements included.

Therapy areas

  • Rare diseases
  • Cardiovascular
  • Oncology & haematology
  • Women's health
  • Iron deficiency & nephrology
  • Hospital & general medicine
03

Where I've worked

  • 2022 — present

    Medical Affairs Lead · CSL Vifor, London

    Design and execution of the medical strategy plan. Final signatory for promotional and non-promotional materials. Medical input across marketing, regulatory, market access and commercial; support for field medical teams.

    Interim Head of Field Medical Affairs, Rare Diseases — 2023
  • 2021 — 2022

    Medical Advisor · Daiichi Sankyo UK

    ABPI final signatory for the cardiovascular portfolio. Supported development and delivery of the UK medical affairs strategy and the company's compliance framework.

  • 2020 — 2021

    Medical Review Specialist · MSD UK

    Final signatory review of promotional and non-promotional initiatives from concept to execution. Responsible person for a range of oncology products, including commercial agreements with partner companies, and launch planning for new indications.

  • 2019 — 2020

    Medical Information Specialist · Pfizer

    Responsible person for women's health products. Escalated enquiry responses, trend analysis for therapeutic teams, and cross-border projects with global colleagues.

  • 2017 — 2019

    Drug Safety & Information Officer · Wockhardt UK

    Medical information and pharmacovigilance: adverse drug reaction processing, product quality complaints, and training of junior team members.

  • 2015 — 2017

    Rotational Clinical Pharmacist · Cambridge University Hospitals NHS FT

    Rotations across clinical trials, oncology and haemato-oncology (including end-checking of cytotoxics), neurology, surgery, general and elderly medicine, biologics and home care.

  • 2010 — 2015

    Pharmacist · Lloydspharmacy (UK) & Farmácia Moderna (Portugal)

    Community pharmacy practice in two countries — where the habit of explaining medicine plainly to the people who take it was formed.

04

Credentials

Education

  • MPharm, Pharmaceutical SciencesFaculdade de Farmácia, Universidade de Lisboa
  • Postgraduate Diploma, Pharmacy PracticeUniversity of Hertfordshire

Registrations

  • Registered PharmacistGeneral Pharmaceutical Council (GPhC)
  • ABPI Final SignatoryCertifying materials under the ABPI Code of Practice since 2020

Languages

  • PortugueseNative
  • EnglishNative
  • Spanish & FrenchProfessional working
  • GreekLimited working

Get in touch

If your team needs medical affairs judgement it can rely on, let's talk.

I'm based in London and work with pharmaceutical teams across the UK and Europe. The best way to reach me is on LinkedIn.